Conference Presentation
Healx Shares Their IMPACT-FXS Trial
August 29, 2022
00 h 14 m
Healx presents during the 2022 Industry Updates Keynote at the 18th International Fragile X Conference.
About the Presentation
With Wayne Chadwick
Wayne Chadwick, a Principal Pharmacologist at Healx Ltd., presented about the IMPACT-FXS trial during the Industry Updates keynote session at the 18th International Fragile X Conference.
IMPACT-FXS is a Phase 2 trial targeting multiple pathways associated with Fragile X to maximize the number of behaviors treated in individuals with Fragile X syndrome.
Wayne shared more about Healx, its novel AI approach to finding treatments, and its Phase 2 trial.
Related Webinars and Videos
